These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Ingle L, Rigby AS, Carroll S, Butterly R, King RF, Cooke CB, Cleland JG, Clark AL. Eur Heart J; 2007 Mar; 28(5):560-8. PubMed ID: 17314108 [Abstract] [Full Text] [Related]
8. The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. Curtis JP, Rathore SS, Wang Y, Krumholz HM. J Card Fail; 2004 Feb; 10(1):9-14. PubMed ID: 14966769 [Abstract] [Full Text] [Related]
9. Prognostic value of the QRS duration in patients with heart failure: a subgroup analysis from 24 centers of Val-HeFT. Hofmann M, Bauer R, Handrock R, Weidinger G, Goedel-Meinen L. J Card Fail; 2005 Sep; 11(7):523-8. PubMed ID: 16198248 [Abstract] [Full Text] [Related]
11. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy. Castel MA, Méndez F, Tamborero D, Mont L, Magnani S, Tolosana JM, Berruezo A, Godoy M, Sitges M, Vidal B, Roig E, Brugada J. Europace; 2009 Mar; 11(3):338-42. PubMed ID: 19136491 [Abstract] [Full Text] [Related]
13. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, Galanti G, Gensini GF. Eur J Heart Fail; 2003 Jun; 5(3):247-52. PubMed ID: 12798821 [Abstract] [Full Text] [Related]
15. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR. J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [Abstract] [Full Text] [Related]
16. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure. Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A. Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900 [Abstract] [Full Text] [Related]
17. Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis. Kell R, Haunstetter A, Dengler TJ, Zugck C, Kübler W, Haass M. Eur Heart J; 2002 Jan; 23(1):70-8. PubMed ID: 11741364 [Abstract] [Full Text] [Related]
19. The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies. Stempfle HU, Alt A, Stief J, Siebert U. J Heart Lung Transplant; 2008 Feb; 27(2):222-8. PubMed ID: 18267231 [Abstract] [Full Text] [Related]